Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cengiz Demir has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic Characterisation of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates from a Tertiary-Care Hospital in Türkiye

    by Merih Şimşek, Cengiz Demir

    Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a global health threat driven by limited treatment options and high-risk clones. This study aimed to characterise the clonal structure, resistance and virulence determinants and carbapenemase-carrying genetic elements of CRKP isolates from a tertiary-care hospital in Türkiye. Twenty-five isolates, one per patient, were collected between October 2023 and October 2024, tested against EUCAST criteria and sequenced with Oxford Nanopore long reads. Analyses comprised MLST, 2335-locus cgMLST, resistome, virulome, plasmid (MOB-suite), pan-genome (Panaroo) and defence-system profiling. All isolates were carbapenem-resistant, 19 ceftazidime-avibactam-resistant and seven colistin-resistant. Six sequence types and five genetic clusters were identified, with ST147 predominant (n = 13). The commonest carbapenemase profile was blaNDM-5 plus blaOXA-48 (n = 13), followed by blaKPC-3 alone (n = 5) and blaNDM-7 alone (n = 2). blaNDM-5 and blaOXA-48 were mainly carried by conjugative plasmids pAA405 and pAA002, whereas four isolates carried carbapenemases on chromosome-associated or IncX3 elements. blaNDM-5 co-occurred with the aerobactin operon in 15 isolates. The pan-genome comprised 7377 gene clusters, and isolates within a genetic cluster differed phenotypically and genotypically. Resistance and virulence determinants converged within ST147 and on shared plasmids, so genomic surveillance should consider genetic cluster, element architecture and accessory genome together.

  • Open Access

    Syndromic Panel for Investigation of Agents in Patients with Acute Respiratory Tract Infections

    by Selahattin Ünlü, Betül Fatmanur Yıldırım, Cengiz Demir, Melahat Gürbüz, Yeliz Çetinkol

    Aim: The aim of this study was to evaluate the distribution, seasonal variations, co-infection patterns and age group differences of viral and bacterial agents detected by syndromic panel method in patients with acute respiratory tract infection (ARTI).Material and Methods: In this retrospective cross-sectional study conducted in a single center between February 2023 and January 2024, nasopharyngeal swab samples of 453 patients with suspected ARTI were analyzed using QIAstat-Dx Respiratory Panel (Qiagen®). The panel detects 22 viral and atypical bacterial agents. Statistical analyses were performed with SPSS 26.0.Results: At least one agent was detected in 45.2% of patients and positivity was significantly higher in the pediatric group (62.7%) compared to adults (33.2%) (p

  • Periferik T-Hücreli Lenfoma Hastalarının Geriye Dönük Değerlendirmesi: Tek Merkez Gerçek Yaşam Deneyimi

    by Cengiz Kaan Demi̇r, Güldane Cengi̇z Seval, Meltem Kurt Yüksel, Pervin Topçuoğlu, Önder Arslan, Taner Demi̇rEr, Selami Koçak Toprak

  • Distribution of HCV Genotypes in Patients with Chronic Hepatitis C Infection: A Three-Year Single-Center Retrospective Study

    by Melahat Gürbüz, Cengiz Demir, Selahattin Ünlü, Betül Fatmanur Yıldırım, Yeliz Çetinkol

    Objective: Hepatitis C virus (HCV) is a single-stranded, positive-sense RNA virus belonging to the genus Hepacivirus in the Flaviviridae family. It has eight known genotypes and 93 subtypes. HCV can be transmitted through various routes, including blood transfusion, surgical procedures, sexual contact, and intravenous drug use, leading to both acute and chronic hepatitis. Genotype (GT) determination and viral load assessment are essential for selecting an appropriate antiviral treatment regimen and duration, and for monitoring treatment efficacy. We aimed to ascertain the genotype distribution over a three-year period. Methods: In this study, patients diagnosed with chronic HCV infection and followed at Afyonkarahisar Health Sciences University Health Practice and Research Hospital between July 1, 2020, and June 30, 2023, were retrospectively evaluated for their age, gender, and HCV genotype data. Results: A total of 91 patients’ HCV genotype data were included in the study. The study revealed that 95.6% of the patients were Turkish citizens, while 4.4% were of foreign nationality. Among the 91 patients, 60 (65.9%) were found to have genotype 1b, 12 (13.2%) had genotype 1a, 10 (11%) had genotype 3, 6 (6.6%) had genotype 4, 2 (2.2%) had genotype 2, and one patient (1.1%) had a co-infection of genotypes 3 and 4. Conclusion: Genotype 1b was dominant in our region. Identifying HCV genotypes is important in guiding the prognosis and treatment of chronic HCV infections and monitoring the epidemiologic changes. This information will be of great value in the health policy that targets HCV and in elimination efforts.

  • Investigation of Human Papillomavirus (HPV) Frequency and Genotype Analysis in Cervical Samples

    by Yeliz Çetinkol, Selahattin Ünlü, Melahat Gürbüz, Cengiz Demir

    Aim: Human Papillomaviruses (HPVs) are double-stranded DNA viruses belonging to the Papillomaviridae family. There is ample evidence demonstrating the association of Human Papillomavirus (HPV) with cervical carcinoma. This study aimed to investigate the presence of HPV DNA in cervical swab samples and determine the HPV genotypes in positive samples. Materials and Methods: The three-year results of cervical swab samples sent to the Medical Microbiology Laboratory of Afyonkarahisar Health Sciences University Faculty of Medicine Hospital for screening for HPV DNA presence between January 1, 2020, and December 31, 2022, were retrospectively evaluated in this study. HPV genotyping was performed using the cobas 4800 (cobas® x480) fully automated system (Roche Diagnostics, Indianapolis, USA) for extraction, and the samples were analyzed using the Real-time PCR (cobas® z 480) system following the manufacturer's instructions. Results: HPV-DNA was detected in 415 out of a total of 4960 patients (8.4%), while 4545 (91.6%) tested negative. Evaluation of HPV positivity revealed that the highest positivity rates were observed in HR-HPV at 68%, HPV 16 at 17.3%, and HPV 16 combined with HR-HPV at 8.2%. HPV-DNA positivity was highest at 38% in the 35-44 age group, while it was lowest at 3.4% in patients under 25 years old. Conclusion: Vaccination programs, alongside screening programs, will serve to restrict the spread of infection in at-risk populations and prevent HPV-related cancers. It is believed that nationwide HPV DNA screening studies and vaccination programs targeting HPV infections will be highly effective in reducing the prevalence of cervical cancer.

  • Çeşitli Klinik Örneklerden İzole Edilen Gram-Negatif Anaerop Basillerin Tiplendirilmesi ve Antibiyotik Direnç Profillerinin E-Test Yöntemi ile Belirlenmesi

    by Cengiz Demi̇r, Recep Keşli̇

    The aim of this study was to identify gram-negative anaerobic bacilli isolated from various clinical specimens that were obtained from patients with suspected anaerobic infections and to determine the antibiotic resistance profiles by using the antibiotic concentration gradient method. The study was performed in Afyon Kocatepe University Ahmet Necdet Sezer Research and Practice Hospital, Medical Microbiology Laboratory between 1 November 2014 and 30 October 2015. Two hundred and seventyeight clinical specimens accepted for anaerobic culture were enrolled in the study. All the samples were cultivated anaerobically by using Schaedler agar with 5% defibrinated sheep blood and Schaedler broth. The isolated anaerobic gram-negative bacilli were identified by using both the conventional methods and automated identification system (VITEK 2, bioMerieux, France). Antibiotic susceptibility tests were performed with antibiotic concentration gradient method (E-test, bioMerieux, France); against penicillin G, clindamycin, cefoxitin, metronidazole, moxifloxacin, imipenem, meropenem, ertapenem and doripenem for each isolate. Of the 28 isolated anaerobic gram-negative bacilli; 14 were identified as Bacteroides fragilis group, 9 were Prevotella spp., and 5 were Fusobacterium spp. The highest resistance rate was found against penicillin (78.5%) and resistance rates against clindamycin and cefoxitin were found as 17.8% and 21.4%, respectively. No resistance was found against metronidazole, moxifloxacin, imipenem, meropenem, ertapenem and doripenem. As a result, isolation and identification of anaerobic bacteria are difficult, time-consuming and more expensive when compared with the cost of aerobic culture. The rate of anaerobic bacteria isolation may be increased by obtaining the appropriate clinical specimen and appropriate transportation of these specimens. We believe that the data obtained from the study in our center may offer benefits for the follow up and treatment of infections caused by anaerobic bacteria and may contribute to the current literature. Because of high resistance rate detected against penicillin, this antibiotic should not be used as a first choice in empirical treatment. Cefoxitin may be used in empirical antimicrobial treatment of anaerobic gram-negatives; but the rate of antibiotic resistance should be detected for more useful and proper treatment. The prior selection of the most effective antibiotic, may contribute to decrease the rate of high resistance. In our study, no resistance was observed against carbapenem group antibiotics and metronidazole; so these antibiotics should be reserved as treatment options in the future for infections caused by resistant gram-negative anaerobic bacteria.


  • Molecular Epidemiology of Beta-Lactamases in Ceftazidime-Resistant Pseudomonas aeruginosa Isolates

    by Halil Er, Mustafa Altindi̇ş, Gülşah Aşik, Cengiz Demi̇r

    <%=header_description %> <%=header_description %>